Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27625645 | 0.79 | LMNA (0.44) | LMNAHSP90AA1FFAR1GABRA1ALOX15 | |
| SCHEMBL4055501 | 0.79 | LMNA (0.52) | LMNAHPGDTSHRHSD17B10HSP90AA1 | |
| SCHEMBL21686455 | 0.79 | LMNA (0.69) | LMNAHPGDTSHRHSD17B10HSP90AA1 | |
| SCHEMBL27502850 | 0.74 | MEN1 (0.53) | LMNAHPGDTSHRHSD17B10HSP90AA1 | |
| SCHEMBL27640494 | 0.74 | LMNA (0.44) | LMNAHPGDTSHRHSD17B10HSP90AA1 | |
| SCHEMBL1569648 | 0.74 | LMNA (0.40) | LMNAHPGDTSHRHSD17B10HSP90AA1 | |
| SCHEMBL27646054 | 0.72 | GABRA1 (0.44) | LMNAHPGDHSD17B10HSP90AA1FFAR1 | |
| SCHEMBL485062 | 0.71 | HSP90AA1 (0.42) | LMNAHPGDHSP90AA1ALOX12ALDH1A1 | |
| SCHEMBL38658610 | 0.71 | TSHR (0.43) | LMNATSHRHSD17B10HSP90AA1ALDH1A1 | |
| SCHEMBL27659018 | 0.71 | CYP3A4 (0.38) | LMNAHPGDTSHRHSD17B10GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101855224-B | Equilibrative nucleoside transporter ENT1 inhibitors | JANSSEN PHARMACEUTICA NV | 2012-11-28 | — | — | CN | disclosed |
| CN-102083804-A | 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities | SIGMA TAU RES SWITZERLAND SA | 2011-06-01 | — | — | CN | disclosed |
| CN-101855224-A | Equilibrative nucleoside transporter ENT 1 inhibitors | JANSSEN PHARMACEUTICA NV | 2010-10-06 | — | — | CN | disclosed |
| CN-1771235-B | Isoxazole compounds | VERNALIS CAMBRIDGE LTD | 2010-04-28 | — | — | CN | disclosed |
| CN-1771235-A | Isoxazole compounds | VERNALIS CAMBRIDGE LTD (GB) | 2006-05-10 | — | — | CN | disclosed |
| CN-1744894-A | 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitor for the treatment of cancer | VERNALIS CAMBRIDGE LTD (GB) | 2006-03-08 | — | — | CN | disclosed |
| CN-1738804-A | Pyrazole compounds | VERNALIS CAMBRIDGE LTD (GB) | 2006-02-22 | — | — | CN | disclosed |